Eric Schmidt will begin campaigning on a personal level not as CEO of Google. It's hardly a risky move, but Google is seeking leverage on Capitol Hill.
|
Search king reports earnings per share that beat expectations amid economic and advertising concerns. Shares pick up 8 percent in after-hours trading.
|
Google brings up Microsoft's monopolistic past; Redmond says competition is good.It's about more than search.
|
Google's top three execs had pledged to work together for 20 years in a pact they made shortly before the company's 2004 IPO, according to a report.
|
The search king introduces a Linux-based mobile operating system from Android, a startup Google acquired in 2005, and an alliance of 34 mobile companies.
|
Unfearful of the masses spending time on social networks, Google execs say they don't have to own everything on the Internet and hint Microsoft may have overpaid for a stake in Facebook.
|
Search king reports net income of $1.07 billion on revenue of $4.23 billion, beating analyst expectations.
|
Revenue
growth still strong, but profit misses expectations.
|
Search king discloses that Uncle Sam has questioned its income tax accounting.
|
Search giant faces challenges in 2007
|
Eric Schmidt has been elected to join the computer maker’s board of directors.
|
Search king signs with KDDI in Japan and talks with China Mobile.
|
Don’t write Microsoft off when it comes to online ads, says CEO Steve Ballmer.
|
For anyone confused, Google reminds the world it’s a search engine.
|
CEO Eric Schmidt reiterates his defense for Google's compromise, but not in earshot of the officials.
|
Search giant is hit by friendly fire for second time this week as it mistakenly publishes outdated financial projections.
|
Google mistakenly published its plan to act as the world’s hard drive, but project may be doomed in climate of privacy concerns.
|
Analysts left the GooglePlex happy with search giant’s prospects.
|
During its analyst day event, the search giant sought to calm Wall Street’s jitters.
|
Amgen shares slip as the company posts disappointing earnings instead of much-anticipated data on its cancer drug.
|
Page
1
of
2
|